Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Diabetes Leaders Lilly, Sanofi Give A Glimpse Of GLP-1 Strategy

14 Jun 2012

• By Lisa LaMotta

Related Content

GSK Airs Phase III Data For Weekly GLP-1 Albiglutide, Plans To File By Year-End

03 Apr 2012

Riding High, <em>Victoza</em> Hopes To Gain Ground Over Popular DPP-4s With Label Change

16 Apr 2012

Insulin The Focus At ADA 2012, But Don’t Forget GLP-1s And SGLT-2s

07 Jun 2012

Roche/Ipsen's Suspended Taspoglutide Could Become Another Diabetes Casualty

10 Sep 2010

Related Companies

Sanofi

Eli Lilly and Company

Bristol Myers Squibb Company

Novo Nordisk A/S

GSK plc

Roche Holding AG

Ipsen SA

American Diabetes Association

Zealand Pharma A/S

Additional Topics

Business Strategies Clinical Trials BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.